Drugs / Flunisolide

Regulatory milestones approvals, filings & regulatory actions · 3 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansion US (FDA) AEROSPAN HFA — 2013-08-28 fda.gov ↗
Label expansion US (FDA) NASALIDE — 1999-02-25 fda.gov ↗
Approved US (FDA) NASALIDE — 1981-09-24 fda.gov ↗

Trials 2

today
US approved 1981
NCT00346775 · Ph 3
198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT00203684 — asthma, lung disorder University of California, Los Angeles Completed No outcome recorded
Phase 31 trial
Phase 3 NCT00346775 May → Jun 2006 perennial allergic rhinitis GlaxoSmithKline Completed No outcome recorded
Comparator or background therapy3 trials
— NCT02509299 Background Sep → Nov 2019 chronic obstructive pulmonary disease University of Granada Completed No outcome recorded
— NCT02515318 Comparator Sep 2015 → Mar 2017 chronic obstructive pulmonary disease University of Granada Unknown No outcome recorded
— NCT02404103 Comparator Mar 2015 → May 2017 childhood onset asthma University of Louisville Completed No outcome recorded

Evidence & citations 19 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as Flunisolide “Inhaled glucocorticoids including beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate and triamcinolone acetonide, depending on the expert criteria.” NCT02509299 ↗
4

“Inhaled glucocorticoids including beclomethasone dipropionate, budesonide, flunisolide, fluticasone propionate and triamcinolone acetonide” NCT02515318 ↗

NCT00203684 ↗

NCT00346775 ↗

NCT02404103 ↗

Known as Aerobid ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Aerospan ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Aerospan hfa ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Flunisolida ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Flunisolide anhydrous ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Flunisolide hemihydrate ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Flunisolide-CFC “an inhaled corticosteroid that has a large particle size and should only reach the large airways (Flunisolide-CFC)” NCT00203684 ↗
Known as Flunisolide-HFA “an inhaled, small particle corticosteroid that should reach both the large and small airways (Flunisolide-HFA)” NCT00203684 ↗
Known as Nasalide ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Nasarel ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as NSC-757871 ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as RS-3999 ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Syntaris ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Known as Syntaris hayfever ChEMBL registry synonym — accepted as the source's own label CHEMBL1512 ↗
Action Activate “Glucocorticoid receptor agonist” CHEMBL1512 ↗
Modality Small molecule — CHEMBL1512 ↗
Route Inhaled “Patients will receive inhaled Flunisolide HFA 80 mcg twice per day” NCT02404103 ↗
Target NR3C1 “Glucocorticoid receptor agonist” CHEMBL1512 ↗